Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

20 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Association Between Bone Mineral Density and Autoantibodies in Patients With Rheumatoid Arthritis.
Amkreutz JAMP, de Moel EC, Theander L, Willim M, Heimans L, Nilsson JÅ, Karlsson MK, Huizinga TWJ, Åkesson KE, Jacobsson LTH, Allaart CF, Turesson C, van der Woude D. Amkreutz JAMP, et al. Among authors: heimans l. Arthritis Rheumatol. 2021 Jun;73(6):921-930. doi: 10.1002/art.41623. Epub 2021 May 10. Arthritis Rheumatol. 2021. PMID: 33314699 Free PMC article.
Four-month metacarpal bone mineral density loss predicts radiological joint damage progression after 1 year in patients with early rheumatoid arthritis: exploratory analyses from the IMPROVED study.
Wevers-de Boer KV, Heimans L, Visser K, Kälvesten J, Goekoop RJ, van Oosterhout M, Harbers JB, Bijkerk C, Steup-Beekman M, de Buck MP, de Sonnaville PB, Huizinga TW, Allaart CF. Wevers-de Boer KV, et al. Among authors: heimans l. Ann Rheum Dis. 2015 Feb;74(2):341-6. doi: 10.1136/annrheumdis-2013-203749. Epub 2013 Nov 27. Ann Rheum Dis. 2015. PMID: 24285491 Clinical Trial.
Determinants of reaching drug-free remission in patients with early rheumatoid or undifferentiated arthritis after one year of remission-steered treatment.
Wevers-de Boer KV, Heimans L, Visser K, Schouffoer AA, Molenaar ET, van Groenendael JH, Peeters AJ, Speyer I, Collée G, Huizinga TW, Allaart CF. Wevers-de Boer KV, et al. Among authors: heimans l. Rheumatology (Oxford). 2015 Aug;54(8):1380-4. doi: 10.1093/rheumatology/keu477. Epub 2015 Feb 15. Rheumatology (Oxford). 2015. PMID: 25687553
Two-year results of disease activity score (DAS)-remission-steered treatment strategies aiming at drug-free remission in early arthritis patients (the IMPROVED-study).
Heimans L, Akdemir G, Boer KV, Goekoop-Ruiterman YP, Molenaar ET, van Groenendael JH, Peeters AJ, Steup-Beekman GM, Lard LR, de Sonnaville PB, Grillet BA, Huizinga TW, Allaart CF. Heimans L, et al. Arthritis Res Ther. 2016 Jan 21;18:23. doi: 10.1186/s13075-015-0912-y. Arthritis Res Ther. 2016. PMID: 26794605 Free PMC article. Clinical Trial.
Remission induction therapy with methotrexate and prednisone in patients with early rheumatoid and undifferentiated arthritis (the IMPROVED study).
Wevers-de Boer K, Visser K, Heimans L, Ronday HK, Molenaar E, Groenendael JH, Peeters AJ, Westedt ML, Collée G, de Sonnaville PB, Grillet BA, Huizinga TW, Allaart CF. Wevers-de Boer K, et al. Among authors: heimans l. Ann Rheum Dis. 2012 Sep;71(9):1472-7. doi: 10.1136/annrheumdis-2011-200736. Epub 2012 Mar 8. Ann Rheum Dis. 2012. PMID: 22402145 Clinical Trial.
20 results